Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 221Polycystic Ovary Syndrome 36Endometrial Neoplasms 15Ovarian Neoplasms 13Infertility 11Neoplasm Metastasis 9Carcinoma, Intraductal, Noninfiltrating 7Fallopian Tube Neoplasms 6Neoplasms 5Breast Diseases 5Triple Negative Breast Neoplasms 4Osteoporosis 4Leiomyoma 4Infertility, Female 4Breast Neoplasms, Male 4Breast Carcinoma In Situ 4Arthralgia 4Advanced Breast Cancer 4Recurrence 3Obesity 3Breast Cancer Metastatic 3Anovulation 3Uterine Neoplasms 2Solid Tumor 2Prostatic Neoplasms 2Progesterone Resistance 2Pancreatic Neoplasms 2Pain 2Leiomyosarcoma 2HR Positive HER2 Negative Advanced Breast Cancer 2

Interventions

Magnetic Resonance Spectroscopy 2pembrolizumab 1naxitamab 1abemaciclib 1Vorinostat 1Tamoxifen 1Steroids 1Specimen Handling 1Letrozole 1Imatinib Mesylate 1Hormones 1Gemcitabine 1Cyclin-Dependent Kinase Inhibitor p18 1Cyclin-Dependent Kinase Inhibitor p16 1Capecitabine 1Biopsy 116-fluoroestradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage IV Breast Cancer AJCC v8 × Letrozole × Clear all
NCT00338728 2020-01-27

Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
59 enrolled 7 charts
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡